Article Text

PDF

Permanent junctional reciprocating tachycardia in children: a multicentre study on clinical profile and outcome
  1. G Vaksmann1,
  2. C D’Hoinne1,
  3. V Lucet2,
  4. S Guillaumont3,
  5. J-M Lupoglazoff4,
  6. A Chantepie5,
  7. I Denjoy6,
  8. E Villain7,
  9. F Marçon8
  1. 1Department of Paediatric Cardiology, Cardiological Hospital, Lille, France
  2. 2Department of Paediatric Dysrhythmias, Le chateau des côtes, Les Loges en Josas, France
  3. 3Department of Paediatric Cardiology, Montpellier, France
  4. 4Department of Paediatric Cardiology, Robert Debré Hospital, Paris, France
  5. 5Department of Paediatric Cardiology, Trousseau Hospital, Tours, France
  6. 6Department of Electrophysiology, Lariboisiere Hospital, Paris, France
  7. 7Department of Paediatric Cardiology, Necker Hospital, Paris, France
  8. 8Department of Paediatric Cardiology, Paediatric Hospital, Nancy, France
  1. Correspondence to:
    Dr Guy Vaksmann
    Polyclinique de la Louviere, 69 rue de la Louviere, 59800, Lille, France; guy.vaksmann{at}wanadoo.fr

Abstract

Objectives: To investigate the clinical profile, natural history, and optimal management of persistent or permanent junctional reciprocating tachycardia (PJRT) in children.

Methods and results: 85 patients meeting the ECG criteria for PJRT were enrolled in a retrospective multicentre study. Age at diagnosis varied from birth to 20 years (median 3 months). Follow up ranged from 0.1 to 26.0 (median 8.2) years. At the time of referral, 24 of 85 patients (28%) had congestive heart failure that was resolved with medical treatment in all patients. Eighty three patients received drug treatment initially. Amiodarone and verapamil were the most effective with a success rate of 84–94% alone or in association with digoxin. Radiofrequency ablation of the accessory pathway was performed in 18 patients. There was a trend for a relation between age at ablation and the result of the procedure, failures being more common in younger patients (three of six procedures in younger and 15 of 18 in older children were successful; p  =  0.14). Two patients with persistent left ventricular dysfunction on echocardiography but with no symptoms of congestive heart failure died suddenly one month and three years after diagnosis. PJRT resolved spontaneously in 19 patients (22%). Age at diagnosis of PJRT was not a predictor of spontaneous resolution.

Conclusions: PJRT is a potentially lethal arrhythmia in children with tachycardia induced cardiomyopathy. Spontaneous resolution of tachycardia is not uncommon. Antiarrhythmic treatment is often effective. Radiofrequency ablation should be performed in older children or when rate is not controlled, especially in patients with persistent left ventricular dysfunction.

  • children
  • outcome
  • permanent junctional reciprocating tachycardia
  • supraventricular tachycardia

Statistics from Altmetric.com

Persistent or permanent junctional reciprocating tachycardia (PJRT) is an uncommon arrhythmia first described by Coumel et al,1 characterised by an incessant orthodromic tachycardia with anterograde conduction over the atrioventricular node and by retrograde conduction via an accessory pathway usually located in the posteroseptal region with slow and decremental conduction.2–4. The arrhythmia is commonly incessant from birth or infancy, even though it may not be recognised until adulthood.5 Its persistence over a long period of time may lead to a tachycardia induced cardiomyopathy that is reversible with rate control.6,7,8,9,10 PJRT is thought not to have the spontaneous resolution characteristics of other atrioventricular re-entry tachycardias in infancy but spontaneous resolution has been reported in some patients.8 The arrhythmia is considered to be usually refractory to drug treatment and various non-pharmacological approaches have been used to prevent tachycardia or for rate control. Over the past few years radiofrequency catheter ablation of the accessory pathway has been reported to be very effective and safe as definitive treatment of PJRT.11–14 Although most patients having had catheter ablation had reach adulthood, it has been proposed that the technique should be considered early in the management of these patients.14–16 However, because of the rareness of the reports on the natural history of PJRT, little is known about the clinical course of this chronic tachycardia. Single institutional experience of PJRT usually is small, and generally accepted guidelines on how to manage these patients are still lacking. On the basis of a multi-institutional experience reporting the largest population of patients with PJRT, we attempted to determine the clinical profile, natural history, and optimal management of this uncommon arrhythmia.

METHODS

Patient selection

This multicentre retrospective study was conducted at seven French paediatric institutions caring for paediatric arrhythmias. The participating centres and the number of contributed patients are as follows: Les loges en Josas (27 patients), Lille (18 patients), Montpellier (13 patients), Nancy (12 patients), Paris (Necker Hospital, 5 patients; Robert Debré Hospital, 6 patients), and Tours (4 patients). Twenty one of the 85 patients have been the subjects of previous reports.9,10 A questionnaire addressing the patients’ clinical course, treatment, and follow up was given to each centre to complete. Patients were enrolled if they presented with PJRT before their 20th birthday. Follow up of each patient had to be longer than one year unless the affected patient died earlier.

Diagnosis of PJRT was based on surface ECG criteria including the presence of an almost incessant narrow QRS tachycardia with negative P waves in inferior leads, a P′R interval shorter than the RP′ interval, and an atrioventricular ratio of 1:1. During episodes of sinus rhythm the PR interval had to be normal with no evidence of a delta wave. During tachycardia, no episode of functional atrioventricular block could be documented on 24 hour ambulatory recordings or vagal manoeuvres.

All patients were followed up as outpatients. An intracardiac electrophysiological study was performed in 21 patients with subsequent catheter ablation attempted in 18.

Criteria for treatment effectiveness

The results of treatment were assessed by repeated ECGs and 24 hour ambulatory recordings. Treatment success was defined as conversion to stable permanent sinus rhythm or to predominant sinus rhythm alternating with non-sustained (< 30 seconds) low rate PJRT (< 110 beats/min) with normal left ventricular function on echocardiography. Partial success was defined as a significant decrease in heart rate (PJRT rate reduction > 30%) associated with periods of sustained sinus rhythm on Holter monitoring and normalisation of left ventricular function on echocardiography if dysfunction was initially present. Failure was defined as a non-significant decrease of heart rate or persistence of left ventricular dysfunction if initially present. Spontaneous resolution of PJRT was defined as no recurrence of PJRT after cessation of antiarrhythmic treatment with permanent sinus rhythm on Holter monitoring and an exercise test in patients older than 8 years.

Statistical analysis

Data were compared by Student’s t test for continuous variables. Relative frequencies observed between groups of patients were compared by Fisher’s exact test.

RESULTS

Patient characteristics at presentation

The 85 patients (43 female and 42 male patients) were admitted for incessant tachycardia in 1966–1998. The initial age at diagnosis varied from birth to 20 years (median age 3 months); 57 of 85 patients presented before 1 year of age and 19 of them had a history of intrauterine tachycardia (three with hydrops fetalis), although the type of tachycardia could not be ascertained from the fetal echocardiogram (fig 1). One patient with Williams syndrome had a mitral valve prolapse with grade 2 mitral regurgitation. No other patient had a structural heart defect.

Figure 1

 Distribution of patients by age at diagnosis of tachycardia. IU, in utero diagnosis.

At the time of referral, 24 of 85 patients (28%) presented with varying degrees of congestive heart failure. Congestive heart failure was more common in infants (21 of 57 (37%)) than in children older than 1 year (three of 28 (11%), p < 0.05). Infants had a higher tachycardia rate than did older children (221 (40) v 180 (44) beats/min, p < 0.01). However, the ventricular rate in those patients with congestive heart failure was not significantly different from that in patients without congestive heart failure (217 (30) v 205 (50) beats/min, p > 0.05).

Follow up and treatment

Follow up ranged from 0.1 to 26.0 (median 8.2) years. Of all patients, two never received drug treatment: one because of low rate tachycardia of 100 beats/min, normal left ventricular function, and absence of symptoms; and the other because of primary radiofrequency ablation procedure and with a well tolerated tachycardia of 150 beats/min.

Eighty three patients received drug treatment initially. Among them, only 17 were managed with one single antiarrhythmic drug, whereas 66 received at least two consecutive antiarrhythmic agents. None received more than one antiarrhythmic drug simultaneously, except in combination with digoxin. Of these, 24 even received consecutively four to nine antiarrhythmic drugs (fig 2).

Figure 2

 Number of concomitant or consecutive antiarrhythmic agents given to the patients over the whole study period.

Figure 3 shows a comparison of the effectiveness (complete and partial success) of the antiarrhythmic agents used. The reported initial success rate was highest for amiodarone and verapamil, which were effective or partially effective alone or in association with digoxin in 84–94% of patients. Verapamil was given if patients were older than 2 years. Digoxin alone had a success rate of 52%. PJRT relapsed after initial success in six patients: four were receiving digoxin, one received digoxin and amiodarone, and one received verapamil. The four patients with relapse while taking digoxin were successfully treated with amiodarone (three patients) or verapamil (one patient). The other two patients underwent successful radiofrequency ablation of their accessory pathway.

Figure 3

 Effectiveness of the antiarrhythmic agents. Amio, amiodarone; BB, β blockers; Class I, class I antiarrhythmic agents; Digo, digoxin; Vera, verapamil.

Treatment side effect occurred in 12 patients. Two had chemical evidence of hyperthyroidism and four had chemical evidence of hypothyroidism. None had clinical manifestations of thyroid dysfunction and laboratory values normalised after cessation of the drug. Photosensitivity occurred in three other patients who received amiodarone. Corneal microdeposits were found in only one patient receiving amiodarone but were not systematically searched. Two patients receiving flecainide or propafenone had post-tachycardic pauses on Holter monitoring of more than three seconds suggesting sinus node dysfunction.

Radiofrequency ablation of the accessory pathway was performed in 18 patients by experienced operators from four institutions in 1988–1998 for a total of 24 procedures. Median age at ablation was 17.5 years (range 4–25 years). Ablation was successful at the first attempt in 14 patients including the patient with mitral valve prolapse, at the second attempt in three patients, and at the fourth attempt in one patient. There was a trend for a relation between age at ablation and the result of the procedure, failures being more frequent in younger patients. Three of six procedures performed in children younger than 10 years were successful compared with 15 of 18 procedures performed in older children (p  =  0.14).

When initially present, congestive heart failure resolved with medical treatment in all patients. However, two patients with a persistent decreased left ventricular ejection fraction on echocardiography, but no symptoms of congestive heart failure died, suddenly. The first one was a 4 year old boy who had pulmonary oedema at admission. He was treated with amiodarone and died one month after the onset of treatment despite rate control and improvement of clinical symptoms and of left ventricular ejection fraction. The second one was a 9 year old girl who received digoxin for three years and was thought to be in good control under treatment but with persistent left ventricular dilatation on echocardiography with a left ventricular ejection fraction of 45%.

PJRT resolved spontaneously in 19 patients (22%) 5.4 years (two months to 16 years) after diagnosis of tachycardia. Median follow up after spontaneous resolution was 2.2 years (range 0.3–11.9 years). Age at diagnosis of PJRT was not a predictor of spontaneous resolution. Spontaneous resolution occurred in 14 of 57 (25%) of patients younger than 1 year and in five of 28 (18%) of patients older than 1 year at diagnosis (not significant).

Status at last follow up

At last follow up, 36 patients (42%) were free of PJRT on Holter monitoring or exercise testing and free of pharmacological treatment, including the 19 patients who had spontaneous resolution and the 17 with successful radiofrequency ablation. Twenty six patients (31%) were also free of PJRT on Holter monitoring but were still treated with antiarrhythmic drugs. Five patients (6%) had a low rate PJRT or had an initially incessant tachycardia that became non-sustained and were not treated, among them the patient who was never treated. Only 18 patients (21%) had PJRT while receiving drugs, among them the two patients who died suddenly. None of the remaining 16 patients had clinical symptoms or impairment of left ventricular function on echocardiography.

DISCUSSION

This multicentre study, having collected data on a large number of patients with PJRT, confirmed some findings and brought to light some new characteristics useful for the management of this rare arrhythmia.

Clinical profile

PJRT may be diagnosed at any age during childhood but is diagnosed in a majority of patients during infancy or prenatally. Symptoms of congestive heart failure were more common among younger patients before the introduction of medical treatment. Patients who are older at diagnosis of PJRT probably have had unrecognised slower tachycardia that was less sustained during early childhood, explaining their better tolerance and their late diagnosis. Congestive heart failure always resolved with antiarrhythmic treatment. Nevertheless, two patients with persistent left ventricular dysfunction on echocardiography, although clinically improved by treatment, died suddenly one month and five years after diagnosis.

Unlike accessory pathways of the Wolff-Parkinson-White syndrome in children that are associated with a structural heart defect in about one third of patients,17–21 accessory pathways of PJRT are generally isolated. Only one patient of this series with the Williams syndrome had a structural heart defect. In addition, no patients in two other large published series of 53 patients had a structural cardiac anomaly.8,22

One of the main findings of the present study is the relatively high rate of spontaneous resolution of PJRT, which exceeded 20%. In contrast with observations in smaller series of paediatric patients reported so far, spontaneous resolution of PJRT was not so uncommon.8,22 Such resolution happened sometimes many years after diagnosis of tachycardia.

Another interesting finding of this study is the remarkable effectiveness of some antiarrhythmic drugs against arrhythmia, especially amiodarone and verapamil, which had a success rate of more than 80%. Even patients receiving digoxin alone had a success rate of more than 50%. In our series, radiofrequency ablation had a greater success rate in older patients. In addition, although radiofrequency ablation can be performed at any age, even in infancy, complications in this age group are more common.23–25 Furthermore, experimental data have shown that radiofrequency lesions appear to increase in size with somatic growth, with replacement of normal myocytes with fibrous and elastic tissue forming a potential arrhythmogenic substrate.26 Thus, considering the high success rate of antiarrhythmic drugs, we recommend that patients with PJRT be treated initially with amiodarone or verapamil in combination with digoxin. The usual effectiveness of these drugs may allow delay of radiofrequency ablation until patients have grown adequately.

Study limitations

Firstly, the present study was a retrospective and multicentre investigation. However, it enrolled a large number of patients with relatively uniform management. In all the centres, medical treatment was tried first, especially with younger patients, and radiofrequency ablation was a first choice procedure for only one patient. Ablation was undertaken in the other patients after failure of medical treatment or occurrence of side effects or on reaching adulthood.

Secondly, electrophysiological study was not mandatory for patient inclusion. However, ECG and Holter monitoring studies allowed the exclusion of the diagnosis of ectopic atrial tachycardia. Intranodal re-entry, in its rarer form (fast-slow), is another possibility but such a tachycardia is very uncommon in children. We do not believe that the absence of electrophysiological study for patient inclusion changed the conclusions of our study.

Thirdly, an exercise test was not mandatory to consider that antiarrhythmic treatment was successful. However, the goal of treatment was not to obtain permanent sinus rhythm but to avoid sustained high frequency (> 110 beats/min) tachycardia on Holter monitoring. However, children older than 8 years who did not receive antiarrhythmic treatment underwent an exercise test to confirm either spontaneous resolution of the tachycardia or success of radiofrequency ablation.

Conclusion

PJRT is a potentially lethal arrhythmia in children with tachycardia induced cardiomyopathy. Although rarely reported, spontaneous resolution is not uncommon. Antiarrhythmic treatment is often effective, especially with amiodarone and verapamil. Radiofrequency ablation should be reserved for older patients but may be indicated even in the very young when the rate is not controlled and especially in patients with persistent left ventricular dysfunction.

REFERENCES

View Abstract

Footnotes

  • Published Online First 7 April 2005

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.